NO995039L - Gastrisk bibeholdt farmasoeytisk preparat - Google Patents

Gastrisk bibeholdt farmasoeytisk preparat

Info

Publication number
NO995039L
NO995039L NO995039A NO995039A NO995039L NO 995039 L NO995039 L NO 995039L NO 995039 A NO995039 A NO 995039A NO 995039 A NO995039 A NO 995039A NO 995039 L NO995039 L NO 995039L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
gastric retained
retained pharmaceutical
gastric
preparation
Prior art date
Application number
NO995039A
Other languages
English (en)
Other versions
NO995039D0 (no
Inventor
Jerome Besse
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995039D0 publication Critical patent/NO995039D0/no
Publication of NO995039L publication Critical patent/NO995039L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995039A 1997-04-18 1999-10-15 Gastrisk bibeholdt farmasoeytisk preparat NO995039L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique
PCT/FR1998/000755 WO1998047506A1 (fr) 1997-04-18 1998-04-15 Composition pharmaceutique a residence gastrique

Publications (2)

Publication Number Publication Date
NO995039D0 NO995039D0 (no) 1999-10-15
NO995039L true NO995039L (no) 1999-12-17

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995039A NO995039L (no) 1997-04-18 1999-10-15 Gastrisk bibeholdt farmasoeytisk preparat

Country Status (19)

Country Link
EP (1) EP0983065A1 (no)
JP (1) JP2001523241A (no)
KR (1) KR20010006353A (no)
CN (1) CN1252720A (no)
AR (1) AR015586A1 (no)
AU (1) AU737634B2 (no)
CA (1) CA2286081A1 (no)
FR (1) FR2762213B1 (no)
HU (1) HUP0002455A3 (no)
IL (1) IL131995A0 (no)
JO (1) JO2017B1 (no)
MA (1) MA26482A1 (no)
NO (1) NO995039L (no)
NZ (1) NZ500288A (no)
PE (1) PE68199A1 (no)
PL (1) PL336273A1 (no)
TN (1) TNSN98049A1 (no)
WO (1) WO1998047506A1 (no)
ZA (1) ZA983258B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2009157711A2 (ko) * 2008-06-24 2009-12-30 Park Eun-Seok 위장체류형 다공성 정제 및 그의 제조 방법
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
CA3084953A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
MX2020005517A (es) 2017-12-05 2020-11-09 Sunovion Pharmaceuticals Inc Formas cristalinas y metodos de produccion de las mismas.
JP7044649B2 (ja) * 2018-06-28 2022-03-30 株式会社ファンケル 胃内浮遊錠剤
SG11202113266YA (en) 2019-06-04 2021-12-30 Sunovion Pharmaceuticals Inc Modified release formulations and uses thereof
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials

Also Published As

Publication number Publication date
CN1252720A (zh) 2000-05-10
IL131995A0 (en) 2001-03-19
CA2286081A1 (en) 1998-10-29
PE68199A1 (es) 1999-07-15
JP2001523241A (ja) 2001-11-20
PL336273A1 (en) 2000-06-19
AU737634B2 (en) 2001-08-23
AR015586A1 (es) 2001-05-16
FR2762213B1 (fr) 1999-05-14
FR2762213A1 (fr) 1998-10-23
NZ500288A (en) 2001-03-30
JO2017B1 (en) 1999-05-15
TNSN98049A1 (fr) 2005-03-15
AU7341698A (en) 1998-11-13
NO995039D0 (no) 1999-10-15
MA26482A1 (fr) 2004-12-20
ZA983258B (en) 1998-10-19
WO1998047506A1 (fr) 1998-10-29
HUP0002455A2 (hu) 2000-12-28
HUP0002455A3 (en) 2001-01-29
KR20010006353A (ko) 2001-01-26
EP0983065A1 (fr) 2000-03-08

Similar Documents

Publication Publication Date Title
NO20001612D0 (no) Oralt preparat
NO973612D0 (no) Nytt farmasöytisk preparat
NO20001776L (no) Medikamenter
NO20005399L (no) Farmasöytisk preparat
NO996372D0 (no) Fast farmasoeytisk preparat inneholdende benzofuanderivater
NO20001160L (no) Nytt skumdannende farmasøytisk preparat
ID24654A (id) Formulasi farmasi omeprazola
NO943888D0 (no) Farmasöytisk preparat
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
NO983624D0 (no) Biocid preparat i fast form
NO994003D0 (no) Farmasöytisk blanding
DK1466615T3 (da) Farmaceutisk præparat
NO20015149D0 (no) Nytt farmasöytisk preparat
DK1017392T3 (da) Lægemiddel
NO995039L (no) Gastrisk bibeholdt farmasoeytisk preparat
NO20015148D0 (no) Nytt farmasöytisk preparat
NO973610D0 (no) Nytt farmasöytisk preparat
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
NO20015104D0 (no) Nytt farmasöytisk preparat
NO973611D0 (no) Nytt farmasöytisk preparat
NO950950D0 (no) Farmasöytisk preparat
NO20015105L (no) Nytt farmasöytisk preparat
NO20021036L (no) Farmasöytisk preparat
ID23531A (id) Komposisi farmasi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application